# Misoprostol for Reduction of Blood Loss During Fibroid Surgery

> **NCT02209545** · PHASE4 · TERMINATED · sponsor: **Northwestern University** · enrollment: 47 (actual)

## Conditions studied

- Fibroids

## Interventions

- **DRUG:** Misoprostol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02209545
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2022-07
- **Final completion:** 2022-07
- **Target enrollment:** 47 (ACTUAL)
- **Why stopped:** The study was prematurely closed due to low enrollment rates.
- **Last updated:** 2023-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02209545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02209545, "Misoprostol for Reduction of Blood Loss During Fibroid Surgery". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02209545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*